Molina director receives quarterly stock grant

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Lockhart Stephen H reported acquisition or exercise transactions in this Form 4 filing.

Molina Healthcare, Inc. director Stephen H. Lockhart received a grant of 405 shares of common stock on April 1, 2026 under the company’s 2025 Equity Incentive Plan. The grant was valued at $55,000 based on a closing share price of $135.82, bringing his direct holdings to 4,147 shares.

This award represents one quarter of an annual equity grant of $220,000 provided to each director, with similar grants scheduled on the first day of each quarter using that day’s closing stock price.

Insider Trade Summary

Grant/Award: 405 shares

Grant/Award 1 txn

Insider Lockhart Stephen H

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	405	$135.82	$55K

Holdings After Transaction: Common Stock — 4,147 shares (Direct)

Footnotes (3)

1. F1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.
2. F2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.
3. F3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Key Figures

Shares granted: 405 shares Grant price: $135.82 per share Quarterly equity value: $55,000 +2 more

5 metrics

Shares granted 405 shares Director stock grant on April 1, 2026

Grant price $135.82 per share Closing price on April 1, 2026

Quarterly equity value $55,000 One quarter of annual director equity award

Annual director equity award $220,000 Total annual equity value per director

Shares owned after grant 4,147 shares Director holdings following April 1, 2026 award

Key Terms

2025 Equity Incentive Plan, annual equity award, Common Stock, director

4 terms

2025 Equity Incentive Plan financial

"Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection..."

annual equity award financial

"The aggregate dollar value of the annual equity award to each director..."

Common Stock financial

"The closing price of the Issuer's common stock on April 1, 2026 was $135.82..."

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

director financial

"in connection with the Reporting Person's services as a Director."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MOH director Stephen Lockhart report?

Stephen H. Lockhart reported receiving 405 shares of Molina Healthcare common stock as a director equity grant. The award was made on April 1, 2026 under the 2025 Equity Incentive Plan and is part of his regular board compensation.

How was Stephen Lockhart’s MOH stock grant value determined?

The grant value was set at $55,000, calculated using Molina Healthcare’s April 1, 2026 closing price of $135.82 per share. Dividing the $55,000 quarterly equity value by $135.82 resulted in an award of 405 common shares.

What is the total annual equity award for Molina Healthcare (MOH) directors?

Each Molina Healthcare director receives an annual equity award valued at $220,000. This compensation is split into four equal quarterly grants of $55,000 each, issued on the first day of each quarter based on that day’s closing common stock price.

How many MOH shares does Stephen Lockhart hold after this grant?

After the April 1, 2026 equity grant, Stephen H. Lockhart directly holds 4,147 shares of Molina Healthcare common stock. This figure reflects his position following the 405-share award granted as part of his director compensation package.

Under which plan was the latest MOH director equity grant issued?

The April 1, 2026 stock grant to Stephen H. Lockhart was issued under Molina Healthcare’s 2025 Equity Incentive Plan. This plan governs the company’s equity-based compensation to directors, including the scheduled quarterly stock awards described in the filing footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lockhart Stephen H

(Last) (First) (Middle)

200 OCEANGATE

SUITE 100

(Street)

LONG BEACH CALIFORNIA 90802

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MOLINA HEALTHCARE, INC. [ MOH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A(1)		405(2)	A	$135.82(3)	4,147	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of stock under the Issuer's 2025 Equity Incentive Plan in connection with the Reporting Person's services as a Director.

2. The aggregate dollar value of the annual equity award to each director was set at $220,000, with one quarter, or $55,000, to be granted on the first day of each quarter, based on the closing price of the Issuer's common stock on such day. The closing price of the Issuer's common stock on April 1, 2026 was $135.82, which resulted in a grant of 405 shares.

3. Represents the closing price of the Issuer's common stock on April 1, 2026.

Remarks:

	Jeff D. Barlow, by power of attorney for Stephen H. Lockhart.	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)